Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease

Background. Several cardiovascular manifestations of coronavirus disease 2019 (COVID-19) have been previously described. QT prolongation has been reported in COVID-19 infection in association with medications such as azithromycin, hydroxychloroquine, and chloroquine but has not previously been repor...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark Coyle, Mark Wilkinson, Mark Sheehy
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2021/9931405
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850228945533796352
author Mark Coyle
Mark Wilkinson
Mark Sheehy
author_facet Mark Coyle
Mark Wilkinson
Mark Sheehy
author_sort Mark Coyle
collection DOAJ
description Background. Several cardiovascular manifestations of coronavirus disease 2019 (COVID-19) have been previously described. QT prolongation has been reported in COVID-19 infection in association with medications such as azithromycin, hydroxychloroquine, and chloroquine but has not previously been reported as a direct result of COVID-19 infection. Case summary. We report the case of a 65-year-old female who developed a prolonged corrected QT interval (QTc) during a hospital admission with COVID-19. This patient was not on any QT prolonging treatment, serum electrolytes were normal, and there was no identifiable reversible cause for the QTc lengthening. Daily serial ECGs during admission showed resolution of the ventricular repolarization abnormality in synchronization with resolution of her COVID-19 viral illness. Discussions. Although there have been reports of QTc prolongation in COVID-19 patients, previous reports of this are for patients receiving medication that causes QT prolongation. This case uniquely demonstrates the development and resolution of this temporary ventricular repolarization abnormality in a patient with a structurally normal heart with no evidence of myocardial fibrosis or edema on cardiac MRI, that is unexplained by other confounding factors, such as medication. This suggests there may be a direct association between COVID-19 and temporary QTc prolongation.
format Article
id doaj-art-26626e325aa4497ca0e539e5495b9d3d
institution OA Journals
issn 2090-6404
2090-6412
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-26626e325aa4497ca0e539e5495b9d3d2025-08-20T02:04:23ZengWileyCase Reports in Cardiology2090-64042090-64122021-01-01202110.1155/2021/99314059931405Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID DiseaseMark Coyle0Mark Wilkinson1Mark Sheehy2Department of Medicine, Midlands Regional Hospital Mullingar, Longford Road, Robinstown, Mullingar, Westmeath, IrelandDepartment of Medicine, Midlands Regional Hospital Mullingar, Longford Road, Robinstown, Mullingar, Westmeath, IrelandDepartment of Medicine, Midlands Regional Hospital Mullingar, Longford Road, Robinstown, Mullingar, Westmeath, IrelandBackground. Several cardiovascular manifestations of coronavirus disease 2019 (COVID-19) have been previously described. QT prolongation has been reported in COVID-19 infection in association with medications such as azithromycin, hydroxychloroquine, and chloroquine but has not previously been reported as a direct result of COVID-19 infection. Case summary. We report the case of a 65-year-old female who developed a prolonged corrected QT interval (QTc) during a hospital admission with COVID-19. This patient was not on any QT prolonging treatment, serum electrolytes were normal, and there was no identifiable reversible cause for the QTc lengthening. Daily serial ECGs during admission showed resolution of the ventricular repolarization abnormality in synchronization with resolution of her COVID-19 viral illness. Discussions. Although there have been reports of QTc prolongation in COVID-19 patients, previous reports of this are for patients receiving medication that causes QT prolongation. This case uniquely demonstrates the development and resolution of this temporary ventricular repolarization abnormality in a patient with a structurally normal heart with no evidence of myocardial fibrosis or edema on cardiac MRI, that is unexplained by other confounding factors, such as medication. This suggests there may be a direct association between COVID-19 and temporary QTc prolongation.http://dx.doi.org/10.1155/2021/9931405
spellingShingle Mark Coyle
Mark Wilkinson
Mark Sheehy
Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease
Case Reports in Cardiology
title Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease
title_full Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease
title_fullStr Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease
title_full_unstemmed Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease
title_short Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease
title_sort otherwise unexplained transient qtc prolongation in a patient admitted with covid disease
url http://dx.doi.org/10.1155/2021/9931405
work_keys_str_mv AT markcoyle otherwiseunexplainedtransientqtcprolongationinapatientadmittedwithcoviddisease
AT markwilkinson otherwiseunexplainedtransientqtcprolongationinapatientadmittedwithcoviddisease
AT marksheehy otherwiseunexplainedtransientqtcprolongationinapatientadmittedwithcoviddisease